2E63

ICD-11 MMS 2026-01

Melanoma in situ neoplasms

Description

Stage 0 includes: Tis, N0, M0. Tis: Melanoma in situ. N0: No regional lymph node metastases. M0: No detectable evidence of distant metastases.

Child codes

  • 2E63.0 – Melanoma in situ of skin
  • 2E63.1 – Melanoma in situ of conjunctiva
  • 2E63.Y – Melanoma in situ neoplasms, other specified site
  • 2E63.Z – Melanoma in situ neoplasms, unspecified site

Sibling codes

  • 2E60 – Carcinoma in situ of oral cavity, oesophagus or stomach
  • 2E61 – Carcinoma in situ of other or unspecified digestive organs
  • 2E62 – Carcinoma in situ of middle ear or respiratory system
  • 2E64 – Carcinoma in situ of skin
  • 2E65 – Carcinoma in situ of breast
  • 2E66 – Carcinoma in situ of cervix uteri
  • 2E67 – Carcinoma in situ of other or unspecified genital organs
  • 2E68 – Carcinoma in situ of bladder
  • 2E69 – Carcinoma in situ of other or unspecified urinary organs
  • 2E6A – Carcinoma in situ of the eye or ocular adnexa
  • 2E6B – Carcinoma in situ of thyroid or other endocrine glands
  • 2E6Y – Carcinoma in situ of other specified site
  • 2E6Z – Carcinoma in situ of unspecified site

Foundation entity

Melanoma in situ neoplasms – http://id.who.int/icd/entity/1576650184

Allowed postcoordination axes

Part of: 02: Neoplasms